Larsen, Jens et al
"Glucagon-Like Peptide-1 Infusion Must Be Maintained for 24 h/day to Obtain Acceptable Glycemia in Type 2 Diabetic Patients Who Are Poorly Controlled on Sulphonylurea Treatment." Diabetes Care
24.8
(2001):
1416-1421.
Web. 16 April. 2021.
